Annex 2B Antimalarial drug policy, 2013

P. falciparum
WHO region
African

Country/area
Algeria
Angola
Benin
Botswana
Burkina Faso
Burundi
Cabo Verde
Cameroon
Central African Republic
Chad
Comoros
Congo
Cte d'Ivoire
Democratic Republic of the Congo
Equatorial Guinea
Eritrea
Ethiopia
Gabon
Gambia
Ghana
Guinea
Guinea-Bissau
Kenya
Liberia
Madagascar
Malawi
Mali
Mauritania
Mayotte, France
Mozambique
Namibia
Niger
Nigeria
Rwanda
Sao Tome and Principe
Senegal
Sierra Leone
South Africa
South Sudan
Swaziland
Togo
Uganda
United Republic of Tanzania
Mainland
Zanzibar
Zambia
Zimbabwe

Uncomplicated
unconfirmed
AL
AL
AL
AL ;AS+AQ
AS+AQ
AL
AS+AQ
AL
AL ;AS+AQ
AL
AS+AQ
AS+AQ
AS+AQ
AS+AQ
AS+AQ
AL
AS+AQ
AL
AS+AQ
AS+AQ
AL
AL
AS+AQ
AS+AQ
AL
AS+AQ
AS+AQ
AL
AL
AL
AL ;AS+AQ
AL
AS+AQ
AS+AQ
AS+AQ
AS+AQ
AL ;AS+AQ
AL
AL ;AS+AQ
AL
AS+AQ
AL
AL

Uncomplicated
confirmed
AL
AL
AL
AL ;AS+AQ
AS+AQ
AL
AS+AQ
AL
AL ;AS+AQ
AL
AS+AQ
AS+AQ
AS+AQ
AS+AQ
AS+AQ
AL
AS+AQ
AL
AL ;AS+AQ
AS+AQ
AL
AL
AS+AQ
AS+AQ
AL
AL ;AS+AQ
AL ;AS+AQ
AL
AL
AL
AL
AL ;AS+AQ
AL
AS+AQ
AL ;AS+AQ
AL ;AS+AQ
AL ;QN+CL ;QN+D
AS+AQ
AL
AL ;AS+AQ
AL
AL ;AS+AQ
AL
AS+AQ
AL
AL

P.vivax
Severe
QN
QN
QN
QN
QN
QN
AM ;QN
AM ;QN
AM ;QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
QN
AM ;AS ;QN
AS
QN
QN
AM ;QN
QN
AM ;AS ;QN
QN
QN
QN
QN
QN
QN
QN
QN

Prevention during
pregnancy
SP(IPT)
SP(IPT)
CQ+PG
SP(IPT)
CQ
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
CQ+PG
SP(IPT)
CQ+PG
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)
SP(IPT)

Treatment
CQ
AS+AQ+PQ
CQ
CQ+PQ
AL
AL+PQ ;CQ+PQ
AS+AQ+PQ
-

Annex 2B Antimalarial drug policy, 2013

P. falciparum
WHO region
Eastern Mediterranean

European

Region of the Americas

South-East Asia

Country/area
Afghanistan
Djibouti
Iran (Islamic Republic of)
Pakistan
Saudi Arabia
Somalia
Sudan
Yemen
Azerbaijan
Kyrgyzstan
Tajikistan
Turkey
Uzbekistan
Argentina
Belize
Bolivia (Plurinational State of)
Brazil
Colombia
Costa Rica
Dominican Republic
Ecuador
El Salvador
French Guiana, France
Guatemala
Guyana
Haiti
Honduras
Mexico
Nicaragua
Panama
Paraguay
Peru
Suriname
Venezuela (Bolivarian Republic of)
Bangladesh
Bhutan
Democratic People's Republic of K
India
Indonesia
Myanmar
Nepal
Sri Lanka
Thailand
Timor-Leste

Uncomplicated
unconfirmed
CQ
AL
CQ
AS+SP
AS+SP
AS+SP
AS+SP
CQ
CQ
-

Uncomplicated
confirmed
AS+SP+PQ
AL+PQ
AS+SP ;AS+SP+PQ
AS+SP+PQ
AS+SP+PQ
AS+SP
AS+SP
AS+SP
AS+SP
AL
AL+PQ
CQ+PQ (1d)
AS+MQ+PQ
AL+PQ(1d) ;AS+MQ+PQ(1d)
AL
CQ+PQ(1d)
CQ+PQ(1d)
AL+PQ
CQ+PQ(1d)
AL ;AT+PG
CQ+PQ(3d)
AL+PQ(1d)
CQ+PQ(1d)
CQ+PQ(1d)
CQ+PQ
CQ+PQ(1d)
AL+PQ(1d)
AL+PQ
AS+MQ
AL+PQ
AS+MQ+PQ
AL
AL
AS+SP+PQ
AS+AQ
;DHA-PP+PQ
AL
;AM ;AS+MQ
;DHAPPQ ;PQ
AL+PQ
AL+PQ
AS+MQ
AL

Severe
AM ;AS ;QN
QN
AS ;QN+D
AS ;QN
AM ;AS ;QN
AS ;QN
AM ;QN
AM ;QN
AS ;QN
QN
QN
QN
AM+CL ;AS+CL ;QN+CL
AS
QN
CQ ;QN
QN
QN
AS ;QN+D
CQ
AM
QN
QN
QN
QN
AS
AS+MQ
AS
AM ;QN
AM ;QN
AM ;QN
AM ;AS ;QN
AM ;AS ;QN
AM ;AS ;QN
AS ;QN
QN
QN+D
AM ;AS ;QN

P.vivax
Prevention during
pregnancy
-

Treatment
CQ+PQ(8w)
CQ+PQ (14 days)
CQ+PQ(14d & 8w)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ
AL+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ
CQ+PQ(14d)
CQ+PQ(7d)
CQ+PQ(7d)
CQ+PQ(14d)
CQ+PQ(7d);CQ+PQ(14d
)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ
CQ+PQ(7d)
CQ+PQ(7d);CQ+PQ(14d
)
CQ+PQ
CQ+PQ
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
AS+AQ
;DHAPP+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)
CQ+PQ(14d)

Annex 2B Antimalarial drug policy, 2013

P. falciparum
WHO region
Western Pacific

Country/area
Cambodia
China
Lao People's Democratic Republic
Malaysia
Papua New Guinea
Philippines
Republic of Korea
Solomon Islands
Vanuatu
Viet Nam

AL=Artemether-lumefantrine
AM=Artemether
AQ=Amodiaquine
ART=Artemisinin

AS=Artesunate
AT= Atovaquone
CL=Clindamycline
CQ=Chloroquine

Uncomplicated
unconfirmed
AL
CQ
AL
-

D=Doxycycline
DHA=Dihydroartemisinin
MQ=Mefloquine
NQ=Naphroquine

Uncomplicated
confirmed
AS+MQ
;DHA-PPQ+PQ
ART+NQ
;ART-PPQ
;AS+AQ ;DHA-PPQ
AL
AS+MQ
AL
AL+PQ
AL
AL
DHA-PPQ

PG=Proguanil
PPQ=Piperaquine
PQ=Primaquine
PYR=Pyronaridine

P.vivax
Severe
AM ;QN
AM ;AS ;PYR
AS+AL
QN+T
AM ;AS
QN+T
AL ;AS
QN
AS ;QN

Prevention during
pregnancy
SP(IPT)
SP(IPT)
SP(IPT)
CQ
CQ(weekly)
CQ(weekly)

Treatment
DHA-PPQ
CQ+PQ(8d)
AL
CQ+PQ(14d)
AL+PQ
CQ+PQ(14d)
CQ+PQ(14d)
AL+PQ(14d)
AL+PQ(14d)
CQ+PQ(14d)

QN=Quinine
SP=Sulphadoxine-pyrimethamine
T=Tetracycline

In May 2013 South Sudan was reassigned to the Who African Region (WHA resolution 66.21 http://apps.who.int/gb/ebwha/pdf_fi les/WHA66/A66_R21-en.pdf ). Nonetheless, since most data in this report precede 2013, South Sudan is placed in Eastern Mediterranean Region